Cargando…

Neurological manifestations in autoinflammatory syndromes: a series of 131 patients from our neuroimmunology departement

Detalles Bibliográficos
Autores principales:	Schuh, E, Lohse, P, Havla, J, Meinl, I, Gerdes, L-A, Hohlfeld, R, Kümpfel, T
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4598895/ http://dx.doi.org/10.1186/1546-0096-13-S1-P150

Ejemplares similares

P02-030 - Unusual CNS manifestation
por: Schuh, E, et al.
Publicado: (2013)

Diversity in clinical manifestations of autoinflammatory syndromes
por: Boiu, S, et al.
Publicado: (2011)

Expanding spectrum of neurologic manifestations in patients with NLRP3 low-penetrance mutations
por: Schuh, Elisabeth, et al.
Publicado: (2015)

Neurological phenotypes in patients with NLRP3-, MEFV-, and TNFRSF1A low-penetrance variants
por: Mulazzani, Elisabeth, et al.
Publicado: (2020)

PW02-032 - CNS manifestations and NLRP3/CIAS1 gene mutations
por: Kümpfel, T, et al.
Publicado: (2013)

SARS-CoV-2 antibody seroprevalence in a large neuroimmunological patient cohort
por: Eisenhut, Katharina, et al.
Publicado: (2021)

Recommendations for the management of autoinflammatory diseases
por: ter Haar, N, et al.
Publicado: (2015)

Therapy of autoinflammatory diseases: a review of the literature
por: ter Haar, NM, et al.
Publicado: (2011)

Canakinumab for the treatment of different refractory autoinflammatory disorders
por: Grein, Ingrid HR, et al.
Publicado: (2014)

Development of the autoinflammatory disease damage index (ADDI)
por: Annink, K, et al.
Publicado: (2015)

Familial Mediterranean Fever and Human autoinflammatory diseases
por: Hovhannisyan, L
Publicado: (2015)

Neurology® Neuroimmunology & Neuroinflammation Acknowledgment to Reviewers
por: Dalmau, Josep O.
Publicado: (2022)

First manifestation of multiple sclerosis after immunization with the Pfizer-BioNTech COVID-19 vaccine
por: Havla, Joachim, et al.
Publicado: (2021)

Therapy of autoinflammatory diseases: results from an international registry
por: ter Haar, NM, et al.
Publicado: (2011)

PReS-FINAL-2210: Qualitative aspects of autoinflammatory diseases
por: Konukbay, D, et al.
Publicado: (2013)

NLRP12- associated autoinflammatory disorder: case report
por: Volpe, Giuseppina, et al.
Publicado: (2014)

Clinical experiences with canakinumab as a treatment for autoinflammatory disorders
por: Saperia, C, et al.
Publicado: (2015)

Unexplained recurrent arthritis as presenting sign of hereditary autoinflammatory syndromes
por: Zulian, F, et al.
Publicado: (2011)

PReS-FINAL-2329: Validation of the autoinflammatory activity index (AIDAI)
por: Piram, M, et al.
Publicado: (2013)

Anti-CD20 B-cell depletion enhances monocyte reactivity in neuroimmunological disorders
por: Lehmann-Horn, Klaus, et al.
Publicado: (2011)

The Eurofever Registry for autoinflammatory diseases: results of the first 15 months of enrolment
por: Toplak, N, et al.
Publicado: (2011)

Determinants of health-related quality of life in children and adults with autoinflammatory diseases
por: Erbis, G, et al.
Publicado: (2015)

Development and validation of juvenile autoinflammatory disease multidimensional assessment report (JAIMAR)
por: Konukbay, D, et al.
Publicado: (2015)

Interleukin-1-related cytokines as potential biomarkers in autoinflammatory skin diseases
por: Bonnekoh, H, et al.
Publicado: (2015)

Studying patients with autoinflammatory diseases: the past, present, and a perspective for the future
por: Hausmann, JS, et al.
Publicado: (2015)

Effects of Natalizumab Therapy on Intrathecal Immunoglobulin G Production Indicate Targeting of Plasmablasts
por: Schlüter, Miriam, et al.
Publicado: (2021)

Migraine in neurological department of fann teaching hospital in Dakar
por: Seck, LB, et al.
Publicado: (2013)

Anti-CD20 therapies and pregnancy in neuroimmunologic disorders: A cohort study from Germany
por: Kümpfel, Tania, et al.
Publicado: (2020)

Monogenetic autoinflammatory syndromes and nephrology - therapy is usefull even in advanced kidney failure
por: Hohenstein-Scheibenecker, K, et al.
Publicado: (2015)

Anti-interleukin 1 treatment in secondary renal amyloidosis associated with autoinflammatory diseases
por: Topaloglu, R, et al.
Publicado: (2015)

Implementation of home measurement of CRP levels in diagnosis and monitoring of children with autoinflammatory diseases
por: Wolska-Kuśnierz, B, et al.
Publicado: (2015)

Clavicular cortical hyperostosis: new autoinflammatory entity or part of the juvenile spondyloarthropathies clinical picture?
por: Lamot, L, et al.
Publicado: (2011)

PReS-FINAL-2236: Continuous autoinflammatory syndromes: a single-center experience in Argentina
por: Russo, RA, et al.
Publicado: (2013)

Monogenic and multifactorial autoinflammatory diseases: Clinical and laboratory characterization in a pediatric Saudi population
por: Al-Mayouf, S, et al.
Publicado: (2015)

Single center experience in Next Generation Sequencing for genetic diagnosis of Autoinflammatory Disorders (AIDs)
por: Lepri, FR, et al.
Publicado: (2015)

A heterozygous variant in MEFV in a familial autoinflammatory syndrome with PAPA-like features
por: Jéru, I, et al.
Publicado: (2015)

Cutaneous Manifestations of Autoinflammatory Diseases
por: Wu, Di, et al.
Publicado: (2021)

Autoinflammatory manifestations in adult patients
por: Rodolfi, Stefano, et al.
Publicado: (2022)

Patients who walk out from our Emergency Departments; is alcohol an issue?
por: OCallaghan, B, et al.
Publicado: (2012)

Pamidronate treatment in resistant cases of CRMO – our small case series
por: Vrtíková, Eva, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_hcq753l6ubmv6l9jctroo0gnbg